FDA Warns Indian API Maker for Water Monitoring, OOS Investigation

Drug Industry Daily
A A
The FDA issued a warning letter to an API manufacturer in Gujarat, India for using untested water in manufacturing and for invalidating an out-of-specification test result without justification.

To View This Article:

Login

Subscribe To Drug Industry Daily